Abstract:AIM Adenosine receptors and extracellular adenosine have been demonstrated to modulate vascular smooth muscle cell (VSMC) proliferation and neointima formation. Adenosine kinase (ADK) is a major enzyme regulating intracellular adenosine levels, but is function in VSMC remains unclear. Here, we investigated the role of ADK in vascular injury-induced smooth muscle proliferation and delineated the mechanisms underlying its action. METHODS AND RESULTS We found that ADK expression was higher in the neointima of injured vessels and in PDGF-treated VSMCs. Genetic and pharmacological inhibition of ADK was enough to attenuate arterial injury-induced neointima formation due to inhibition of VSMC proliferation. Mechanistically, using infinium methylation assays and bisulfite sequencing, we showed that ADK metabolized the intracellular adenosine and potentiated the transmethylation pathway, then induced the aberrant DNA hypermethylation. Pharmacological inhibition of aberrant DNA hypermethylation increased KLF4 expression and suppressed VSMC proliferation as well as the neointima formation. Importantly, in human femoral arteries, we observed increased ADK expression and DNA hypermethylation as well as decreased KLF4 expression in neointimal VSMCs of stenotic vessels suggesting that our findings in mice are relevant for human disease and may hold translational significance. CONCLUSIONS Our study unravels a novel mechanism by which ADK promotes VSMC proliferation via inducing aberrant DNA hypermethylation, thereby downregulating KLF4 expression and promoting neointima formation. These findings advance the possibility of targeting ADK as an epigenetic modulator to combat vascular injury. TRANSLATIONAL PERSPECTIVE Abnormal proliferation of vascular smooth muscle cell (VSMC) is key to abundant occlusive vascular diseases in humans, such as atherosclerosis and intimal hyperplasia associated with restenosis. Adenosine has been shown to combat abnormal smooth muscle proliferation. Here, we demonstrate that increased catabolism of adenosine by adenosine kinase (ADK) promotes abnormal VSMC proliferation. The pathological ADK overexpression in both mice and humans with vascular disease promotes VSMC proliferation via inducing aberrant DNA hypermethylation and KLF4 downregulation. Our study suggests that pharmacological augmentation of endogenous adenosine by targeting ADK represents a promising therapeutic strategy for occlusive vascular diseases.

Adenosine kinase is critical for neointima formation after vascular injury by inducing aberrant DNA hypermethylation.

A2B Adenosine Receptor-Mediated Induction of IL-6 Promotes CKD.

Abstract 14743: Intracellular Adenosine Suppresses Vsmc Phenotypic Switch Through Klf4 Gene Methylation

Adenosine Kinase Inhibition Protects Mice from Abdominal Aortic Aneurysm Via Epigenetic Modulation of VSMC Inflammation

Inhibition of Polycomb Repressor Complex 2 Ameliorates Neointimal Hyperplasia by Suppressing Trimethylation of H3K27 in Vascular Smooth Muscle Cells.

Abstract 10: Endothelial Intracellular Adenosine Epigenetically Regulates Angiogenesis

Abstract 057: Adenosine Kinase Epigenetically Regulates Abdominal Aortic Aneurysm Formation

Intracellular adenosine regulates epigenetic programming in endothelial cells to promote angiogenesis

Regulation of endothelial intracellular adenosine via adenosine kinase epigenetically modulates vascular inflammation

Abstract 12514: Elevated Intracellular Adenosine Epigenetically Regulates Endothelial Inflammation <i>(Best of Basic Science Abstract)</i>

Adenosine kinase promotes post-infarction cardiac repair by epigenetically maintaining reparative macrophage phenotype

Adenosine Kinase Inhibition Enhances Microvascular Dilator Function and Improves Left Ventricle Diastolic Dysfunction

Adenosine Kinase Attenuates Cardiomyocyte Microtubule Stabilization and Protects Against Pressure Overload-Induced Hypertrophy and LV Dysfunction.

Ablation of Myeloid ADK (Adenosine Kinase) Epigenetically Suppresses Atherosclerosis in ApoE-/- (Apolipoprotein E Deficient) Mice

Accumulation of endogenous adenosine improves cardiomyocyte metabolism via epigenetic reprogramming in an ischemia-reperfusion model

Loss of M6a Demethylase ALKBH5 Promotes Post‐ischemic Angiogenesis Via Post‐transcriptional Stabilization of WNT5A

Inhibition of adenosine kinase attenuates myocardial ischaemia/reperfusion injury

AMP-activated protein kinase inhibits vascular smooth muscle cell proliferation and migration and vascular remodeling following injury

Abstract 543: ADAR1-mediated RNA Editing, a Novel Mechanism Controlling Phenotypic Modulation of Vascular Smooth Muscle Cells

Blockade of endothelial adenosine receptor 2 A suppresses atherosclerosis in vivo through inhibiting CREB-ALK5-mediated endothelial to mesenchymal transition

Activation of AMP-activated Protein Kinase Ablated the Formation of Aortic Dissection by Suppressing Vascular Inflammation and Phenotypic Switching of Vascular Smooth Muscle Cells